Azitra, Inc. (NYSEAMERICAN:AZTR – Free Report)’s stock is scheduled to reverse split on Monday, July 1st. The 1-30 reverse split was announced on Monday, July 1st. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, July 1st.
Azitra Price Performance
NYSEAMERICAN:AZTR opened at $0.09 on Friday. The company has a current ratio of 2.80, a quick ratio of 2.80 and a debt-to-equity ratio of 0.01. Azitra has a 12 month low of $0.09 and a 12 month high of $4.33.
Azitra (NYSEAMERICAN:AZTR – Get Free Report) last released its quarterly earnings data on Thursday, May 9th. The company reported ($0.15) earnings per share for the quarter. Azitra had a negative net margin of 1,644.90% and a negative return on equity of 237.52%.
About Azitra
Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.
Further Reading
- Five stocks we like better than Azitra
- What is a SEC Filing?
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Conference Calls and Individual Investors
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- 10 Best Airline Stocks to Buy
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
